CRDF
Cardiff Oncology, Inc.
Key Financials
Operating Income
$-48960000
↓ 0.6%
Revenue
$593000
↓ 13.2%
Shareholders' Equity
$45.4M
↓ 45.3%
Net Income
$-45851000
↓ 0.9%
Total Assets
$61.9M
↓ 36.3%
EPS (Diluted)
$-0.69
↑ 27.4%
Total Liabilities
$16.5M
↑ 15.8%
Cash & Equivalents
$17.5M
↓ 66.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CRDF |
| Company Name | Cardiff Oncology, Inc. |
| CIK | 1213037 |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 858-952-7570 |